If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

DexCom's key Q3 earnings factors include Stelo sales, updates on sales channels, and potential share buybacks. See why I ...

A 10-year-old boy from New Town has been living life to the fullest despite his recent diagnosis of Type 1 diabetes.

DexCom, Inc. (NASDAQ:DXCM) has also consistently beat EPS estimates in the last 4 quarters. The stock has received an average ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

Valeo Financial Advisors LLC raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 31.8% in the third ...

Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...

Ultimately, the right stocks for your portfolio will depend on numerous factors, including your risk tolerance level, ...

Dexcom is launching an over-the-counter continuous glucose monitoring device set to target the over 25 million Type 2 ...

I cleaned the back of my right arm, placed Dexcom's applicator there, pressed the button and popped the CGM right on. It happens fast and doesn't hurt at all. The monitor connects to the Stelo app via ...